← Back to Search

Cancer Vaccine

Increasing Willingness and Uptake of COVID-19 Vaccination for Coronavirus

N/A

Waitlist Available

Led By Sharon Cobb

Research Sponsored by Charles Drew University of Medicine and Science

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up intervention: 4 months; follow-up point: 3 months post-intervention

Awards & highlights

Study Summary

This trial will test a culturally tailored intervention to increase COVID-19 vaccination rates among African American and Latinx public housing residents in South Los Angeles.

Who is the study for?

This trial is for African American and Latinx adults over 18 living in specific South Los Angeles public housing who are hesitant about COVID-19 vaccines. Participants must speak English or Spanish but haven't received all recommended COVID-19 vaccines.Check my eligibility

What is being tested?

The study tests a culturally tailored educational program designed to increase the willingness and actual uptake of COVID-19 vaccinations among vaccine-hesitant residents in underresourced areas.See study design

What are the potential side effects?

Since this trial focuses on education and engagement rather than a medical intervention, it does not involve direct side effects from treatments. However, general side effects of the COVID-19 vaccines can include sore arm, fever, fatigue, headache, muscle pain.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ intervention: 4 months; follow-up point: 3 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~intervention: 4 months; follow-up point: 3 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and intervention: 4 months; follow-up point: 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report

Secondary outcome measures

Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19 vaccine Using the NIH Toolbox Surveys on COVID-19

Percentage of Participants Achieving Increased Level of Behavior Change toward COVID-19 Vaccination Using the NIH Toolbox Surveys on COVID-19

Trial Design

1Treatment groups

Experimental Treatment

Group I: Increasing Uptake of COVID-19 VaccinationExperimental Treatment1 Intervention

This is a pre-experimental "one group pretest-posttest" design to increase COVID-19 vaccine uptake and completion among African American and Latinx public housing residents in South Los Angeles. The proposed intervention will employ (1) culturally sensitive, (2) theoretically based intervention that will be jointly delivered by our ACTIVATE triad leaders and our researchers. We will use the Information, Motivation, and Behavioral Skills (IMB) model and the Transtheoretical Model to implement the intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Charles Drew University of Medicine and ScienceLead Sponsor

51 Previous Clinical Trials

5,887 Total Patients Enrolled

1 Trials studying Vaccine Refusal

Sharon CobbPrincipal InvestigatorCharles R. Drew University of Medicine & Science

1 Previous Clinical Trials

Media Library

Increasing Willingness and Uptake of COVID-19 Vaccination (Cancer Vaccine) Clinical Trial Eligibility Overview. Trial Name: NCT04779138 — N/A

Vaccine Refusal Research Study Groups: Increasing Uptake of COVID-19 Vaccination

Vaccine Refusal Clinical Trial 2023: Increasing Willingness and Uptake of COVID-19 Vaccination Highlights & Side Effects. Trial Name: NCT04779138 — N/A

Increasing Willingness and Uptake of COVID-19 Vaccination (Cancer Vaccine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04779138 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities to participate in this research experiment?

"Clinicaltrials.gov attests that this clinical trial is actively seeking volunteers, which was initially posted on September 11th 2021 and updated as recently as January 26th 2022."

Answered by AI

How many individuals are enrolled in this experiment?

"Affirmative. According to information on clinicaltrials.gov, this medical trial is currently in search of patients. It was initially published on September 11th 2021 and has been updated most recently as of January 26th 2022. The study requires 600 participants from 1 research centre for completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Increasing Vaccine Uptake in Underresourced Public Housing Areas

2021. "Increasing Vaccine Uptake in Underresourced Public Housing Areas". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04779138.